- Home
- SION vs IAUX Comparison
SION vs IAUX Comparison
Compare SION & IAUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SION
- IAUX
- Stock Information
- Founded
- SION 2019
- IAUX 2020
- Country
- SION United States
- IAUX United States
- Employees
- SION N/A
- IAUX N/A
- Industry
- SION
- IAUX
- Sector
- SION
- IAUX
- Exchange
- SION NYSE
- IAUX Nasdaq
- Market Cap
- SION 338.0M
- IAUX 272.2M
- IPO Year
- SION 2025
- IAUX N/A
- Fundamental
- Price
- SION $12.57
- IAUX $0.61
- Analyst Decision
- SION Strong Buy
- IAUX
- Analyst Count
- SION 1
- IAUX 0
- Target Price
- SION $32.00
- IAUX N/A
- AVG Volume (30 Days)
- SION 128.6K
- IAUX 4.5M
- Earning Date
- SION 05-25-2025
- IAUX 05-05-2025
- Dividend Yield
- SION N/A
- IAUX N/A
- EPS Growth
- SION N/A
- IAUX N/A
- EPS
- SION N/A
- IAUX N/A
- Revenue
- SION N/A
- IAUX $55,970,000.00
- Revenue This Year
- SION N/A
- IAUX $102.68
- Revenue Next Year
- SION N/A
- IAUX $52.24
- P/E Ratio
- SION N/A
- IAUX N/A
- Revenue Growth
- SION N/A
- IAUX N/A
- 52 Week Low
- SION $7.26
- IAUX $0.34
- 52 Week High
- SION $25.19
- IAUX $1.44
- Technical
- Relative Strength Index (RSI)
- SION N/A
- IAUX 48.85
- Support Level
- SION N/A
- IAUX $0.56
- Resistance Level
- SION N/A
- IAUX $0.67
- Average True Range (ATR)
- SION 0.00
- IAUX 0.03
- MACD
- SION 0.00
- IAUX 0.00
- Stochastic Oscillator
- SION 0.00
- IAUX 42.78
About SION SIONNA THERAPEUTICS INC
Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefit to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which heads to insufficient CFTR function. The Company is managed as one operating segment focused on the research and development of cystic fibrosis therapies.
About IAUX i-80 Gold Corp.
i-80 Gold Corp is a well-financed gold and silver producer engaged in the exploration, development, and production of gold, silver, and poly-metallic deposits. The Company's principal assets include the Ruby Hill Mine, Lone Tree Mine, Granite Creek Mine, and McCoy-Cove Project.